Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Oligodendrocyte ablation as a tool to study demyelinating diseases.
Acute onset blindness: a case of optic neuritis and review of childhood optic neuritis.
The urinary-specific quality of life of multiple sclerosis patients: Dutch translation and validation of the SF-Qualiveen.
Progressive multifocal leukoencephalopathy.
An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice.
Unveiling alterative splice diversity from human oligodendrocyte proteome data.
Multiple sclerosis: Molecular mimicry of an antimyelin HLA class I restricted T-cell receptor.
Reversible disconnection syndrome in a case of acute tumefactive demyelinating lesion: a PET study.
Recovery from optic neuritis attack in neuromyelitis optica spectrum disorder and multiple sclerosis.
Brain stiffness increases with myelin content.
Terminal complement activation is increased and associated with disease severity in CIDP.
[Fingolimod: effectiveness and safety in routine clinical practice. An observational, retrospective, multi-centre study in Navarra, Gipuzkoa and La Rioja].
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.
Impact of Demographics, Organ Impairment, Disease, Formulation, and Food on the Pharmacokinetics of the Selective S1P1 Receptor Modulator Ponesimod Based on 13 Clinical Studies.
Polygenic control of autoimmune peripheral nerve inflammation in rat.
Vitamin D as an immune modulator in multiple sclerosis, a review.
[The value of brain magnetic resonance imaging in the early diagnosis of neuropsychiatric systemic lupus erythematosus].
Positive correlation between functional disability, excessive daytime sleepiness, and fatigue in relapsing-remitting multiple sclerosis.
Disease-Modifying Drug Possibly Linked to Placental Insufficiency: Severe placental complications in a pregnant woman with multiple sclerosis.
Poster 238 Tumefactive Demyelinating Lesions: Rehabilitation of a Rare, Debilitating Form of Multiple Sclerosis: A Case Report.
GRAPE: a graphical pipeline environment for image analysis in adaptive magnetic resonance imaging.
Fractionation Spares Mice From Radiation-Induced Reductions in Weight Gain But Does Not Prevent Late Oligodendrocyte Lineage Side Effects.
Current trends in autoimmunity and the nervous system.
Multiple sclerosis and employment: Associations of psychological factors and work instability.
Pages
« first
‹ previous
…
705
706
707
708
709
710
711
712
713
…
next ›
last »